UChicago Tech

What UChicago Tech does

UChicago Tech operates as the technology commercialization and entrepreneurship arm of the University of Chicago, functioning through its Polsky Center for Entrepreneurship and Innovation. The organization licenses and transfers technologies developed by University of Chicago researchers to industry partners, corporate licensees, and startup ventures. Its managed portfolio spans approximately 300+ active technologies across 12 categories: Therapeutics, Diagnostics, Research Tools, Medical Devices, Materials, Quantum Sciences, Hardware, Software, Cleantech, Education, Agricultural, and Other. The center supports startup formation through advisory services, accelerator programming, and co-location with the University of Chicago Booth School of Business.

The center's business model is a technology-transfer licensing model. Revenue is generated through upfront licensing fees, development and commercial milestone payments, running royalties on sold products incorporating licensed IP, and sponsored research agreements with corporate partners. Notable inventoried technologies include an AI-enabled PET scan diagnostic and a brain signal decoding algorithm, indicating active licensing activity in AI-adjacent healthcare IP. The center is funded and housed as part of the University of Chicago, with a broader affiliated headcount reported at 10,000+ (representing the university, not the Polsky Center itself).

The organization operates through two named subsidiaries: Third Coast Foundry, which provides a San Francisco-based presence for West Coast deal flow and venture engagement, and the Polsky Center itself. It has established outward-facing partnerships including the India Deep Tech Accelerator with the India Deep Tech Alliance, intended to extend commercialization pathways into India's deep-tech ecosystem. Reported senior leadership is limited to two named business development executives (Mike Hinton and Harrison Paul), suggesting a lean operating team relative to the breadth of the managed portfolio. The center was founded in 1998.

Name

UChicago Tech

Legal name

Polsky Center for Entrepreneurship and Innovation

Website

http://tech.uchicago.edu/

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

UChicago Tech, operating through the Polsky Center for Entrepreneurship and Innovation, is the University of Chicago's technology commercialization arm, licensing a portfolio of 300+ faculty-developed technologies across therapeutics, quantum, software, and other deep-tech domains to corporate partners and spin-out ventures.

Ownership category

akta.pro rank

Product category

Technology Licensing & Commercialization

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

akta.pro secondary industries

Technical Universities with Energy, Materials & Sustainability Focus (EDAHAEAL), Technical Universities with Computing, Data & AI Focus (EDAHAEAK), Technical Universities with Specialized Engineering Domains (EDAHAEAI), Technical Universities with Entrepreneurship & Incubation Focus (EDAHAEAH), STEM-Focused Research Universities (Engineering & Applied Sciences) (EDAHABAB), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)

Keywords

• Technology licensing services
• Academic technology transfer
• University research commercialization
• Sponsored research partnerships
• Startup incubation programs

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Technology Licensing: The Polsky Center licenses University of Chicago technologies to companies for commercialization. Revenue is generated through licensing fees, milestone payments, and royalties based on commercial success of licensed technologies.
2. Sponsored Research: Industry partnerships that fund research activities at the University. Companies partner with the Polsky Center to further develop University-based technologies through sponsored research agreements.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

UChicago Tech operates as the technology licensing and commercialization arm of the University of Chicago, licensing patented university-developed technologies to industry partners across therapeutics, diagnostics, medical devices, quantum sciences, advanced materials, hardware, software, cleantech, education, and agricultural sectors. Revenue is generated through licensing fees, milestone payments, royalties, and sponsored research agreements negotiated on a case-by-case basis with business development managers. The center also runs entrepreneurship programs, startup accelerators, and incubators supporting UChicago students, alumni, founders, faculty, and partner startups.

Product overview

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago operates as a technology licensing and commercialization office. The center offers access to breakthrough, validated technologies available for licensing across multiple industries including therapeutics, diagnostics, medical devices, quantum sciences, advanced materials, hardware, software, cleantech, education, and agricultural sectors. The technology portfolio includes featured technologies such as biocompatible optoelectronic devices for pacemakers, minimally invasive drug delivery systems, and stretchable pressure sensors. Technologies span categories from therapeutics (oncology, gene editing, immunotherapy) and diagnostics to quantum computing, AI/machine learning software, and sustainable cleantech solutions.

Differentiator

Problem solved

Functional benefit

Products and services

• Biocompatible and Flexible Optoelectronic Devices for Next Generation Pacemakers A new class of biocompatible and flexible optoelectronic devices based on semiconductor heterojunctions designed for optical epicardial pacing in vivo, developed for next-generation pacemakers. Available for licensing to medical device companies.
• Minimally Invasive System to Deliver and Retain Drugs in the Kidney A transurethral retrograde system that allows for repeated delivery and retention of drugs into the kidney, available for licensing to medical device and pharmaceutical companies.
• Stretchable and Strain-Insensitive Pressure Sensor A stretchable and strain-insensitive pressure sensor that performs extremely well under strain compared to currently available stretchable pressure sensors, available for licensing to sensor and wearables companies.
• Therapeutics Technology Portfolio A portfolio of licensable therapeutics technologies from the University of Chicago spanning oncology, cellular therapy, gene editing, epigenetics, and immunotherapy, offered to biopharma and therapeutics companies for commercialization.
• Diagnostics Technology Portfolio A portfolio of licensable diagnostic technologies and platforms developed at the University of Chicago, offered to diagnostics and life sciences companies for commercialization.
• Research Tools Technology Portfolio A portfolio of innovative licensable platforms and technologies that accelerate scientific discovery and translational research, offered to life sciences and research tool companies.
• Materials Technology Portfolio A portfolio of engineered materials licensable from the University of Chicago, powering breakthroughs in quantum systems, energy, electronics, and bioengineering.
• Quantum Sciences Technology Portfolio A portfolio of foundational licensable innovations in quantum computing, sensing, communication, and materials from the University of Chicago, offered to quantum technology companies.
• Hardware Technology Portfolio A portfolio of licensable enabling hardware technologies from the University of Chicago for next-generation computing, sensing, communications, and energy systems.
• Software Technology Portfolio

Quantifiable outcome

• Reduces industrial air-conditioning costs by up to 50% (via licensee Albatross liquid-desiccant cooling system)

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature12 records

Partnerships

Three partnerships are on record, tiered core.

• University of Chicago Booth School of BusinesscoreStrategic or Co-development PartnerThe Polsky Center is affiliated with and co-located with the University of Chicago Booth School of Business, leveraging the Booth brand and network for entrepreneurship programs and venture activities.
• India Deep Tech AlliancecoreStrategic or Co-development PartnerStrategic partnership through the India Deep Tech Accelerator program, managed by the Polsky Center, to support IIT-affiliated startups in developing research-driven products into scalable, market-ready offerings for global markets.
• Industry Partners (Multiple Companies)coreTechnology or IntegrationThe Polsky Center has partnered with a number of companies to further develop University-based technologies through licenses and sponsored research. These partnerships enable commercialization of academic research.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Stanford Office of Technology Licensing: Stanford University's central technology transfer office; directly comparable in function — licensing faculty-disclosed inventions across therapeutics, software, hardware, and clean tech to corporate partners — and competes for the same pool of corporate licensees and sponsored research budgets.
• MIT Technology Licensing Office: MIT's technology transfer office manages invention disclosures, patents, and licensing from one of the world's leading STEM research engines. Highly comparable GTM motion: direct industry engagement, sponsored research, and royalty-bearing licenses across physical, life, and engineering sciences.
• Harvard Office of Technology Development: Harvard's central tech transfer and industry collaboration arm, with heavy emphasis on biomedical and life-science licensing plus sponsored research — directly comparable in serving faculty-driven IP commercialization at a Tier-1 private research university.
• UC Berkeley IPIRA (Intellectual Property & Industry Research Alliances): Berkeley's industry alliances and technology licensing office; manages IP, licensing, and sponsored research for the UC Berkeley research enterprise, competing head-to-head with Polsky for engineering, materials, and clean-tech licensees.
• Columbia Technology Ventures: Columbia University's tech transfer and commercialization office, with a portfolio spanning therapeutics, medical devices, software, and clean tech; comparable faculty-disclosure-driven licensing model and industry partnership structure.
• Yale Office of Cooperative Research: Yale's technology transfer and industry collaboration office; directly comparable in managing invention disclosures and licensing across Yale's STEM and biomedical research output.
• Princeton Innovation: Princeton's tech transfer, accelerator, and venture-creation hub — closely comparable model combining faculty IP licensing with startup incubation and industry partnerships.
• Oxford University Innovation: Oxford's technology transfer and consulting company; analogous model of licensing university research across life sciences, physical sciences, and software — a global peer competing for international corporate licensees.
• Cambridge Enterprise: The University of Cambridge's technology transfer office; directly comparable in commercializing inventions from a top-tier research university across biotech, cleantech, AI, and quantum sciences.
• Imperial College Innovations: Imperial College London's technology transfer and commercialization arm; comparable model focused on STEM-driven IP licensing (engineering, materials, life sciences, computing) with corporate sponsored research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/PolskyCenter
• LinkedInlinkedin.com/company/uchicagotech
• Instagraminstagram.com/polskycenter
• Xx.com/UChicagoTech

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UChicago Tech